🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

10624+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Showing 20 of 10624 recruiting trials

Phase 3Enrolling by InvitationNCT06908226

A Study to Investigate LP352 in Children and Adults With Developmental and Epileptic Encephalopathy (DEE)

🏥 Longboard Pharmaceuticals📍 16 sites📅 Started Feb 2025View details ↗
RecruitingNCT06779487

Systemic Biomarkers to Predict Radiation-Induced Neurocognitive Decline

🏥 Tata Memorial Centre📍 1 site📅 Started Feb 2025View details ↗
Phase 2RecruitingNCT06699602

A Study of Cemiplimab and Fianlimab in People With Clear Cell Renal Cell Carcinoma

👨‍⚕️ Martin Voss, MD, Memorial Sloan Kettering Cancer Center📍 7 sites📅 Started Feb 2025View details ↗
Phase 4RecruitingNCT06195241

Effects of DaxibotulinumtoxinA for Blepharospasm and Hemifacial Spasm

👨‍⚕️ Anne Barmettler, MD, Montefiore Medical Center/Albert Einstein College of Medicine📍 1 site📅 Started Feb 2025View details ↗
Phase 1, PHASE2RecruitingNCT06942572

A Phase 1/2, First-in-Human Dose Escalation/Expansion Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of a Subretinal Injection of SB-007 in Subjects With Stargardt Disease (STGD1)

🏥 Splice Bio📍 5 sites📅 Started Feb 2025View details ↗
Phase 4RecruitingNCT06964269

Use of Acthar Gel Single-Dose Pre-Filled SelfJectTM Injector in Patients With Moderate-Severe Keratitis and Autoimmune Disease

🏥 Toyos Clinic📍 1 site📅 Started Feb 2025View details ↗
NARecruitingNCT06951386

The Impact of Daily Intake of Short-chain Fatty Acids on Cardiometabolic Risk Factors in Individuals at Risk for Metabolic Syndrome

👨‍⚕️ Kristin Verbeke, Prof., KU Leuven📍 1 site📅 Started Feb 2025View details ↗
Phase 1RecruitingNCT06941129

CAR T-cell Therapy Targeting CD19 and BCMA in Patients With Relapse/Refractory Autoimmune Diseases

🏥 Institute of Hematology & Blood Diseases Hospital, China📍 1 site📅 Started Feb 2025View details ↗
Phase 3RecruitingNCT06858579

A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)

🏥 Dianthus Therapeutics📍 158 sites📅 Started Feb 2025View details ↗
Phase 1RecruitingNCT06822868

A Clinical Study Exploring CT1190B in the Treatment of Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma

🏥 Kai Hu📍 1 site📅 Started Feb 2025View details ↗
Phase 2RecruitingNCT06541847

A Phase 2, Open-Label Study to Evaluate the Safety and Effects of HLX-1502 in Patients With Neurofibromatosis Type 1

👨‍⚕️ Miriam Bornhorst, Lurie's Children's Hospital📍 13 sites📅 Started Feb 2025View details ↗
NARecruitingNCT06980584

Study on the Treatment of Nonthrombotic Obstructive Pulmonary Hypertension

🏥 Beijing Chao Yang Hospital📍 1 site📅 Started Feb 2025View details ↗
NARecruitingNCT06981611

Vulvodynia Intervention: the Effect of Multimodal Treatment for Provoked Vulvodynia

🏥 Karlstad University📍 1 site📅 Started Feb 2025View details ↗
Phase 3RecruitingNCT06533098

A Study of Nipocalimab or Intravenous Immunoglobulin (IVIG) in Pregnancies At Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)

👨‍⚕️ Janssen Research & Development, LLC Clinical Trial, Janssen Research & Development, LLC📍 22 sites📅 Started Feb 2025View details ↗
RecruitingNCT06887517

Chinese Rheumatism Biobank(CRB)

🏥 Chinese SLE Treatment And Research Group📍 1 site📅 Started Feb 2025View details ↗
Phase 2RecruitingNCT06798415

Intralesional Injection of Metronidazole for the Management of Cutaneous Leishmaniasis

🏥 Hayder Adnan Fawzi📍 1 site📅 Started Feb 2025View details ↗
Phase 1RecruitingNCT06349343

CD19/BCMA CAR-T Cell Therapy for Refractory/Moderate-to-severe Systemic Lupus Erythematosus

👨‍⚕️ Qiubai Li, Professor, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology📍 1 site📅 Started Feb 2025View details ↗
Phase 2RecruitingNCT06863584

SBRT Plus Lenalidomide for Solitary Plasmacytoma: Phase II Trial

🏥 Second Affiliated Hospital, School of Medicine, Zhejiang University📍 1 site📅 Started Feb 2025View details ↗
NARecruitingNCT06649955

Controlling Amyotrophic Lateral Sclerosis Motor Neuron Excitability Study

🏥 PathMaker Neurosystems Inc.📍 1 site📅 Started Feb 2025View details ↗
Phase 2RecruitingNCT06797544

Intralesional Injection of Levofloxacin for the Management of Cutaneous Leishmaniasis

🏥 Hayder Adnan Fawzi📍 1 site📅 Started Feb 2025View details ↗
← PreviousPage 150 of 532Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →